Assertio Holdings reported $166.78M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
ANI Pharmaceuticals USD 239.51M 38.6M Mar/2026
Assertio Holdings USD 166.78M 34.25M Sep/2025
Aurora Cannabis CAD 145.94M 21.82M Dec/2025
Cara Therapeutics USD 11.04M 2K Dec/2025
Daiichi Sankyo JPY 778.55B 77.51B Dec/2025
Ironwood Pharmaceuticals USD 236.31M 5.91M Mar/2026
J&J USD 57.72B 3.59B Mar/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Merck USD 26.94B 1.38B Mar/2026
Nektar Therapeutics USD 53.54M 12.8M Dec/2025
Omeros USD 85.5M 2.28M Jun/2025
Pfizer USD 34.35B 2.64B Mar/2026
Teva Pharmaceutical Industries USD 13.53B 76M Mar/2026